Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
OBJECTIVE: This article describes the design of and difficulties inherent in the execution of a long-term, observational trial that sought to assess the validity of short-term measures of multiple sclerosis (MS) (eg, relapse rate, inflammatory lesions) for long-term disease outcomes. METHODS: In th...
Autores principales: | Ebers, G, Reder, A, Traboulsee, A, Li, D, Langdon, D, Goodin, D, Wolf, C, Beckmann, K, Konieczny, A |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2009
|
Ejemplares similares
-
The final results of the interferon beta-1b 16-year long-term follow-up study
por: Ebers, G, et al.
Publicado: (2006) -
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
por: Goodin, D, et al.
Publicado: (2012) -
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
por: Goodin, D, et al.
Publicado: (2012) -
The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
por: Reder, A, et al.
Publicado: (2008) -
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
por: Reder, A, et al.
Publicado: (2010)